The 38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (ENA 2026) is scheduled to take place in person from November 18–20, 2026, at the CCIB (Centre de Convencions Internacional de Barcelona) in Barcelona, Spain.

This premier international forum, hosted by the European Organisation for Research and Treatment of Cancer (EORTC), the National Cancer Institute (NCI), and the American Association for Cancer Research (AACR), is dedicated to drug development and translational research.

Chaired by Elena Garralda, with co-chairs Ryan Corcoran (AACR) and Tim Greten (NCI), the symposium will feature over 60 international speakers and attract more than 1,200 participants from 41 countries. The program spotlights cutting-edge preclinical and phase I studies, offering over 30 hours of educational sessions focused on molecular biology, target identification, and drug innovation to influence the future of clinical cancer research.